Your browser doesn't support javascript.
loading
Lipofection of Non-integrative CRISPR/Cas9 Ribonucleoproteins in Male Germline Stem Cells: A Simple and Effective Knockout Tool for Germline Genome Engineering.
Obermeier, Mariella; Vadolas, Jim; Verhulst, Stefaan; Goossens, Ellen; Baert, Yoni.
Afiliação
  • Obermeier M; Biology of the Testis Lab, Vrije Universiteit Brussel (VUB), Brussels, Belgium.
  • Vadolas J; Department of Molecular and Translational Sciences, Monash University, Clayton, VIC, Australia.
  • Verhulst S; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, VIC, Australia.
  • Goossens E; Liver Cell Biology Research Group, Vrije Universiteit Brussel (VUB), Brussels, Belgium.
  • Baert Y; Biology of the Testis Lab, Vrije Universiteit Brussel (VUB), Brussels, Belgium.
Front Cell Dev Biol ; 10: 891173, 2022.
Article em En | MEDLINE | ID: mdl-35774227
ABSTRACT
Gene editing in male germline stem (GS) cells is a potent tool to study spermatogenesis and to create transgenic mice. Various engineered nucleases already demonstrated the ability to modify the genome of GS cells. However, current systems are limited by technical complexity diminishing application options. To establish an easier method to mediate gene editing, we tested the lipofection of site-specific Cas9gRNA ribonucleoprotein (RNP) complexes to knockout the enhanced green fluorescent protein (Egfp) in mouse EGFP-GS cells via non-homologous end joining. To monitor whether gene conversion through homology-directed repair events occurred, single-stranded oligodeoxynucleotides were co-lipofected to deliver a Bfp donor sequence. Results showed Egfp knockout in up to 22% of GS cells, which retained their undifferentiated status following transfection, while only less than 0.7% EGFP to BFP conversion was detected in gated GS cells. These data show that CRISPR/Cas9 RNP-based lipofection is a promising system to simply and effectively knock out genes in mouse GS cells. Understanding the genes involved in spermatogenesis could expand therapeutic opportunities for men suffering from infertility.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article